CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation
The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days befor...
Saved in:
| Published in | Journal of radiation research Vol. 54; no. 5; pp. 938 - 942 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Oxford University Press
01.09.2013
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0449-3060 1349-9157 1349-9157 |
| DOI | 10.1093/jrr/rrt030 |
Cover
| Abstract | The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days before surgery. After resection, the size of the tumor on gross pathologic examination was recorded. The maximal measurement in one dimension on axial imaging and pathologic examination was extracted for statistical analysis. The clinical and pathologic sizes were compared using a percent size difference (%Δsize) as an end point. A regression analysis was applied to study the association between pathologic and radiographic size. The median radiographic and pathologic size were 70.58 ± 38.9 mm and 68.59 ± 40.56 mm, respectively. The radiographic size was larger than or equal to the pathologic size in 110/174 tumors (63.2%), and smaller in 64/174 (36.8%) tumors. Overall, the radiographic and pathologic sizes were positively correlated (r = 0.983, P = 0.000). CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median %Δsize was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3–5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%. |
|---|---|
| AbstractList | The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median % Delta size was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3-5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%. The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days before surgery. After resection, the size of the tumor on gross pathologic examination was recorded. The maximal measurement in one dimension on axial imaging and pathologic examination was extracted for statistical analysis. The clinical and pathologic sizes were compared using a percent size difference (%Δsize) as an end point. A regression analysis was applied to study the association between pathologic and radiographic size. The median radiographic and pathologic size were 70.58 ± 38.9 mm and 68.59 ± 40.56 mm, respectively. The radiographic size was larger than or equal to the pathologic size in 110/174 tumors (63.2%), and smaller in 64/174 (36.8%) tumors. Overall, the radiographic and pathologic sizes were positively correlated (r = 0.983, P = 0.000). CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median %Δsize was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3-5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%.The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days before surgery. After resection, the size of the tumor on gross pathologic examination was recorded. The maximal measurement in one dimension on axial imaging and pathologic examination was extracted for statistical analysis. The clinical and pathologic sizes were compared using a percent size difference (%Δsize) as an end point. A regression analysis was applied to study the association between pathologic and radiographic size. The median radiographic and pathologic size were 70.58 ± 38.9 mm and 68.59 ± 40.56 mm, respectively. The radiographic size was larger than or equal to the pathologic size in 110/174 tumors (63.2%), and smaller in 64/174 (36.8%) tumors. Overall, the radiographic and pathologic sizes were positively correlated (r = 0.983, P = 0.000). CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median %Δsize was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3-5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%. The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days before surgery. After resection, the size of the tumor on gross pathologic examination was recorded. The maximal measurement in one dimension on axial imaging and pathologic examination was extracted for statistical analysis. The clinical and pathologic sizes were compared using a percent size difference (%Δsize) as an end point. A regression analysis was applied to study the association between pathologic and radiographic size. The median radiographic and pathologic size were 70.58 ± 38.9 mm and 68.59 ± 40.56 mm, respectively. The radiographic size was larger than or equal to the pathologic size in 110/174 tumors (63.2%), and smaller in 64/174 (36.8%) tumors. Overall, the radiographic and pathologic sizes were positively correlated (r = 0.983, P = 0.000). CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median %Δsize was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3–5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%. The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days before surgery. After resection, the size of the tumor on gross pathologic examination was recorded. The maximal measurement in one dimension on axial imaging and pathologic examination was extracted for statistical analysis. The clinical and pathologic sizes were compared using a percent size difference (%[DELTA]size) as an end point. A regression analysis was applied to study the association between pathologic and radiographic size. The median radiographic and pathologic size were 70.58 ± 38.9 mm and 68.59 ± 40.56 mm, respectively. The radiographic size was larger than or equal to the pathologic size in 110/174 tumors (63.2%), and smaller in 64/174 (36.8%) tumors. Overall, the radiographic and pathologic sizes were positively correlated (r = 0.983, P = 0.000). CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median %[DELTA]size was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3-5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%. The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma (HCC). This analysis included 174 patients with HCC who underwent surgery. Enhanced computed tomography (CT) was performed up to 30 days before surgery. After resection, the size of the tumor on gross pathologic examination was recorded. The maximal measurement in one dimension on axial imaging and pathologic examination was extracted for statistical analysis. The clinical and pathologic sizes were compared using a percent size difference (%[DELTA]size) as an end point. A regression analysis was applied to study the association between pathologic and radiographic size. The median radiographic and pathologic size were 70.58 ± 38.9 mm and 68.59 ± 40.56 mm, respectively. The radiographic size was larger than or equal to the pathologic size in 110/174 tumors (63.2%), and smaller in 64/174 (36.8%) tumors. Overall, the radiographic and pathologic sizes were positively correlated (r = 0.983, P = 0.000). CT seemed to overestimate the tumor size by 2.16 mm compared to final pathology (P = 0.024). The median %[DELTA]size was 3.3%. Pathologic tumor size was significantly underestimated in patients with a tumor size 3-5 cm (P = 0.011), Grade I HCC (P = 0.023), with clear boundary (P = 0.013). We concluded that CT size and pathologic size were positively correlated, but differences did exist. Utilizing the radiographic tumor when planning radiation would have covered 63.2% of gross tumors. For a radiographic tumor size < 50 mm, utilizing a 3-mm margin around the radiographic tumor would have covered 90% of gross lesions, while a margin of 5 mm would have covered 95%, and a margin of 15 mm would have covered 100%. Keywords: hepatocellular carcinoma, CT-pathologic relation, target delineation, radiation |
| Audience | Academic |
| Author | Bai, Yong-rui Hou, Yan-li Chen, Hai-yan Hu, Bin Ma, Xiu-mei Ye, Ming |
| AuthorAffiliation | Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China |
| AuthorAffiliation_xml | – name: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China |
| Author_xml | – sequence: 1 givenname: Hai-yan surname: Chen fullname: Chen, Hai-yan organization: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China – sequence: 2 givenname: Xiu-mei surname: Ma fullname: Ma, Xiu-mei organization: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China – sequence: 3 givenname: Ming surname: Ye fullname: Ye, Ming organization: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China – sequence: 4 givenname: Yan-li surname: Hou fullname: Hou, Yan-li organization: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China – sequence: 5 givenname: Bin surname: Hu fullname: Hu, Bin organization: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China – sequence: 6 givenname: Yong-rui surname: Bai fullname: Bai, Yong-rui email: baiyongrui@renji.com organization: Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23616629$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl9rFDEUxYNU7Lb64geQARFE2fZmMpNJfBDK4j8o-FKfw51MZjdLJhkzM0q_vdmd1dpSquQh4eZ3brgn54Qc-eANIc8pnFGQ7Hwb43mMIzB4RBaUFXIpaVkdkQUU6cyAwzE5GYYtQF5BCU_Icc445TyXC9KsrpY9jpvgwtrqTIcYjcPRBp9Zn_XRdhivs41JTNDGuclhzDRGbX3o8F2Giet6Z_WsaUPMRoxrM2aNcdabffkpedyiG8yzw35Kvn38cLX6vLz8-unL6uJyqUvJxiVvBNZtC6KhZV1QJiSUAliOjS6blnMqkWPJGsZywZkQdY1Qa63bUiDkkLNT8nbuO_ker3-ic-owgaKgdl6p5JWavUr0-5nup7ozjTZ-jHijCGjV7RtvN2odfihWcc72z70-NIjh-2SGUXV22JmE3oRpULQSnAqas-o_0DQTBcHEv9GC0VwWrNhN8PIOug1T9MlixWgFouJS5jfUGp1R1rchTaN3TdVFmYJQFrKiiTq7h0qrMZ3VKXCtTfVbghd_2_fHt9_ZSgDMgI5hGKJplbbjPg-ps3X3f8mbO5IH_-_VDIepf4j7BSLu_e0 |
| CitedBy_id | crossref_primary_10_1016_j_hpb_2023_04_001 crossref_primary_10_1016_j_ejso_2025_109683 crossref_primary_10_1186_s12957_024_03399_1 |
| Cites_doi | 10.1186/1748-717X-5-73 10.1200/JCO.2007.14.3529 10.1200/JCO.2005.01.5354 10.1097/01.coc.0000184657.65679.6f 10.1016/j.ijrobp.2009.01.057 10.1097/PPO.0b013e31816a0e80 10.3322/caac.21161 10.1002/hep.1840160122 10.1016/j.semradonc.2011.05.009 10.1016/j.semradonc.2011.05.002 10.1097/00130404-200409000-00008 10.1007/s12094-010-0492-x 10.1016/j.ijrobp.2006.06.015 10.1016/S0360-3016(02)02864-X 10.1016/j.ctrv.2009.11.008 10.1016/j.semradonc.2011.05.001 10.1080/02841860600897934 |
| ContentType | Journal Article |
| Copyright | Crown Copyright. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology 2013. 2013 COPYRIGHT 2013 Oxford University Press Crown Copyright. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology 2013. |
| Copyright_xml | – notice: Crown Copyright. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology 2013. 2013 – notice: COPYRIGHT 2013 Oxford University Press – notice: Crown Copyright. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology 2013. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8AO 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. M0S P5Z P62 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7U7 C1K 7U5 8FD L7M 5PM ADTOC UNPAY |
| DOI | 10.1093/jrr/rrt030 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials ProQuest Central Technology Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection (Proquest) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Advanced Technologies & Aerospace Collection ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management Solid State and Superconductivity Abstracts Technology Research Database Advanced Technologies Database with Aerospace PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) Advanced Technologies & Aerospace Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management Technology Research Database Advanced Technologies Database with Aerospace Solid State and Superconductivity Abstracts |
| DatabaseTitleList | Toxicology Abstracts MEDLINE - Academic Publicly Available Content Database MEDLINE Technology Research Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1349-9157 |
| EndPage | 942 |
| ExternalDocumentID | 10.1093/jrr/rrt030 PMC3766302 A536154971 23616629 10_1093_jrr_rrt030 |
| Genre | Clinical Trial Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- -~X .I3 0R~ 29L 2WC 4.4 53G 5GY 5VS AAFWJ AAMVS AAOGV AAPPN AAPXW AAVAP AAWTL ABAZT ABEJV ABGNP ABPTD ABQLI ABWST ABXVV ACGFS ADBBV ADHZD ADMLS ADRAZ AENEX AENZO AFFNX AFPKN AGQXC ALMA_UNASSIGNED_HOLDINGS ALUQC AMNDL AOIJS BAWUL BAYMD BCNDV BEFXN BFFAM BGNUA BKEBE BPEOZ BTTYL CIDKT CS3 DIK DU5 D~K E3Z EBS EJD EMOBN F5P GROUPED_DOAJ GX1 H13 HYE IAO IHR INH ITC JAVBF JMI JSF JSH KSI M48 ML0 M~E O9- OAWHX OCL OJQWA OK1 O~Y P2P PEELM RHF RNS ROL ROX RPM RXO TOX TR2 W2D XSB ~D7 7.U 7X7 8AO 8FI 8FJ 8WZ A6W AAYXX ABEFU ABUWG ABVLG ACFRR ACUTJ AFKRA ARAPS BENPR BGLVJ BKOMP CCPQU CITATION FYUFA HCIFZ HH5 HMCUK MOJWN OVT PHGZM PHGZT PIMPY PQGLB PUEGO RJT RZJ TKC UDS UKHRP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FE 8FG 8FK AZQEC DWQXO K9. P62 PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7U7 C1K 7U5 8FD L7M 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c593t-6d8abff08d15b41389058032adc5df6619a6a53d33286388bba0bcccf58a02023 |
| IEDL.DBID | M48 |
| ISSN | 0449-3060 1349-9157 |
| IngestDate | Sun Oct 26 04:16:16 EDT 2025 Tue Sep 30 16:52:25 EDT 2025 Fri Sep 05 10:48:52 EDT 2025 Tue Oct 07 08:07:19 EDT 2025 Thu Sep 04 19:17:59 EDT 2025 Tue Oct 07 06:32:26 EDT 2025 Mon Oct 20 22:12:50 EDT 2025 Mon Oct 20 16:15:52 EDT 2025 Mon Jul 21 06:02:44 EDT 2025 Thu Apr 24 23:12:54 EDT 2025 Wed Oct 01 04:12:32 EDT 2025 Wed Feb 05 08:35:01 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | radiation hepatocellular carcinoma CT-pathologic relation target delineation |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Open Government License (http://www.nationalarchives.gov.uk/doc/open-government-licence/), which permits unrestricted distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c593t-6d8abff08d15b41389058032adc5df6619a6a53d33286388bba0bcccf58a02023 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://academic.oup.com/jrr/article-pdf/54/5/938/11834703/rrt030.pdf |
| PMID | 23616629 |
| PQID | 3170876992 |
| PQPubID | 1976363 |
| PageCount | 5 |
| ParticipantIDs | unpaywall_primary_10_1093_jrr_rrt030 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3766302 proquest_miscellaneous_1786181237 proquest_miscellaneous_1732810838 proquest_miscellaneous_1431294340 proquest_journals_3170876992 gale_infotracmisc_A536154971 gale_infotracacademiconefile_A536154971 pubmed_primary_23616629 crossref_citationtrail_10_1093_jrr_rrt030 crossref_primary_10_1093_jrr_rrt030 oup_primary_10_1093_jrr_rrt030 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-09-01 |
| PublicationDateYYYYMMDD | 2013-09-01 |
| PublicationDate_xml | – month: 09 year: 2013 text: 2013-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | Journal of radiation research |
| PublicationTitleAlternate | J Radiat Res |
| PublicationYear | 2013 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | Ben-Josef ( key 20170511061101_RRT030C8) 2005; 23 Zeng ( key 20170511061101_RRT030C11) 2004; 10 Dawson ( key 20170511061101_RRT030C5) 2008; 14 Barbaba ( key 20170511061101_RRT030C16) 1992; 16 Wang ( key 20170511061101_RRT030C18) 2010; 5 Dawson ( key 20170511061101_RRT030C4) 2011; 21 Parkin ( key 20170511061101_RRT030C1) 2000; 94 Cárdenes ( key 20170511061101_RRT030C14) 2010; 12 Tse ( key 20170511061101_RRT030C13) 2008; 26 Feng ( key 20170511061101_RRT030C7) 2011; 21 Brock ( key 20170511061101_RRT030C3) 2011; 21 Monrex ( key 20170511061101_RRT030C9) 2006; 66 Maluccio ( key 20170511061101_RRT030C2) 2012; 62 Wang ( key 20170511061101_RRT030C17) 2010; 76 Park ( key 20170511061101_RRT030C10) 2002; 54 Kelsey ( key 20170511061101_RRT030C15) 2005; 28 Mendez-Romero ( key 20170511061101_RRT030C12) 2006; 45 Ma ( key 20170511061101_RRT030C6) 2010; 36 16982547 - Acta Oncol. 2006;45(7):831-7 21939856 - Semin Radiat Oncol. 2011 Oct;21(4):271-7 18391616 - Cancer J. 2008 Mar-Apr;14(2):111-6 16317267 - Am J Clin Oncol. 2005 Dec;28(6):576-80 20031332 - Cancer Treat Rev. 2010 Apr;36(2):157-63 19406586 - Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):467-76 15530260 - Cancer J. 2004 Sep-Oct;10(5):307-16 21939852 - Semin Radiat Oncol. 2011 Oct;21(4):241-6 11668491 - Int J Cancer. 2001 Oct 15;94(2):153-6 18172187 - J Clin Oncol. 2008 Feb 1;26(4):657-64 20231127 - Clin Transl Oncol. 2010 Mar;12(3):218-25 1352268 - Hepatology. 1992 Jul;16(1):132-7 21939853 - Semin Radiat Oncol. 2011 Oct;21(4):247-55 16314634 - J Clin Oncol. 2005 Dec 1;23(34):8739-47 20731853 - Radiat Oncol. 2010;5:73 23070690 - CA Cancer J Clin. 2012 Nov-Dec;62(6):394-9 12182985 - Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):150-5 17145534 - Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1152-8 |
| References_xml | – volume: 5 start-page: 73 year: 2010 ident: key 20170511061101_RRT030C18 article-title: Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: definition of clinical target volume for radiotherapy publication-title: Radiat Oncol doi: 10.1186/1748-717X-5-73 – volume: 26 start-page: 657 year: 2008 ident: key 20170511061101_RRT030C13 article-title: Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma publication-title: J Clin Oncol doi: 10.1200/JCO.2007.14.3529 – volume: 23 start-page: 8739 year: 2005 ident: key 20170511061101_RRT030C8 article-title: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies publication-title: J Clin Oncol doi: 10.1200/JCO.2005.01.5354 – volume: 28 start-page: 576 year: 2005 ident: key 20170511061101_RRT030C15 article-title: Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy publication-title: Am J Clin Oncol doi: 10.1097/01.coc.0000184657.65679.6f – volume: 76 start-page: 467 year: 2010 ident: key 20170511061101_RRT030C17 article-title: Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2009.01.057 – volume: 14 start-page: 111 year: 2008 ident: key 20170511061101_RRT030C5 article-title: Hepatocellular carcinoma: radiation therapy publication-title: Cancer J doi: 10.1097/PPO.0b013e31816a0e80 – volume: 94 start-page: 153 year: 2000 ident: key 20170511061101_RRT030C1 article-title: Estimating the world cancer burden: Globocan publication-title: Int J Cancer 2001 – volume: 62 start-page: 394 year: 2012 ident: key 20170511061101_RRT030C2 article-title: Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma publication-title: CA Cancer J Clin doi: 10.3322/caac.21161 – volume: 16 start-page: 132 year: 1992 ident: key 20170511061101_RRT030C16 article-title: Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival publication-title: Hepatology doi: 10.1002/hep.1840160122 – volume: 21 start-page: 241 year: 2011 ident: key 20170511061101_RRT030C4 article-title: Overview: where does radiation therapy fit in the spectrum of liver cancer local–regional therapies? publication-title: Semin Radiat Oncol doi: 10.1016/j.semradonc.2011.05.009 – volume: 21 start-page: 271 year: 2011 ident: key 20170511061101_RRT030C7 article-title: Radiation therapy for hepatocellular carcinoma publication-title: Semin Radiat Oncol doi: 10.1016/j.semradonc.2011.05.002 – volume: 10 start-page: 307 year: 2004 ident: key 20170511061101_RRT030C11 article-title: A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma publication-title: Cancer J doi: 10.1097/00130404-200409000-00008 – volume: 12 start-page: 218 year: 2010 ident: key 20170511061101_RRT030C14 article-title: Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma publication-title: Clin Transl Oncol doi: 10.1007/s12094-010-0492-x – volume: 66 start-page: 1152 year: 2006 ident: key 20170511061101_RRT030C9 article-title: Feasibility and efficacy of high-dose three- dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies—mature results of the French Phase II RTF-1 trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2006.06.015 – volume: 54 start-page: 150 year: 2002 ident: key 20170511061101_RRT030C10 article-title: Dose-response relationship in local radiotherapy for hepatocellular carcinoma publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(02)02864-X – volume: 36 start-page: 157 year: 2010 ident: key 20170511061101_RRT030C6 article-title: Approach to radiation therapy in hepatocellular carcinoma publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2009.11.008 – volume: 21 start-page: 247 year: 2011 ident: key 20170511061101_RRT030C3 article-title: Imaging and image-guided radiation therapy in liver cancer publication-title: Semin Radiat Oncol doi: 10.1016/j.semradonc.2011.05.001 – volume: 45 start-page: 831 year: 2006 ident: key 20170511061101_RRT030C12 article-title: Stereptactic body radiotherapy for primary and metastatic liver tumors: a single institution phase I-II study publication-title: Acta Oncol doi: 10.1080/02841860600897934 – reference: 1352268 - Hepatology. 1992 Jul;16(1):132-7 – reference: 16314634 - J Clin Oncol. 2005 Dec 1;23(34):8739-47 – reference: 20231127 - Clin Transl Oncol. 2010 Mar;12(3):218-25 – reference: 20731853 - Radiat Oncol. 2010;5:73 – reference: 12182985 - Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):150-5 – reference: 21939852 - Semin Radiat Oncol. 2011 Oct;21(4):241-6 – reference: 16982547 - Acta Oncol. 2006;45(7):831-7 – reference: 20031332 - Cancer Treat Rev. 2010 Apr;36(2):157-63 – reference: 23070690 - CA Cancer J Clin. 2012 Nov-Dec;62(6):394-9 – reference: 15530260 - Cancer J. 2004 Sep-Oct;10(5):307-16 – reference: 16317267 - Am J Clin Oncol. 2005 Dec;28(6):576-80 – reference: 18391616 - Cancer J. 2008 Mar-Apr;14(2):111-6 – reference: 18172187 - J Clin Oncol. 2008 Feb 1;26(4):657-64 – reference: 17145534 - Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1152-8 – reference: 21939856 - Semin Radiat Oncol. 2011 Oct;21(4):271-7 – reference: 19406586 - Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):467-76 – reference: 11668491 - Int J Cancer. 2001 Oct 15;94(2):153-6 – reference: 21939853 - Semin Radiat Oncol. 2011 Oct;21(4):247-55 |
| SSID | ssj0027050 |
| Score | 1.9928321 |
| Snippet | The purpose of this investigation was to analyze the correlation between CT size and gross pathologic size for subjects with primary hepatocellular carcinoma... |
| SourceID | unpaywall pubmedcentral proquest gale pubmed crossref oup |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 938 |
| SubjectTerms | Adult Aged Boundaries Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - surgery CAT scans China - epidemiology Comparative analysis Computed tomography Correlation Covering Delineation Diagnostic imaging Female Hepatocellular carcinoma Humans Liver cancer Liver Neoplasms - diagnosis Liver Neoplasms - epidemiology Liver Neoplasms - surgery Male Middle Aged Neoplasm Invasiveness Oncology Pathology Patients Prevalence Radiation (Physics) Regression analysis Reproducibility of Results Sensitivity and Specificity Statistical analysis Statistics as Topic Surgery Tomography, X-Ray Computed - statistics & numerical data Tumor Burden Tumors |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-6lK17GVv35S0rGiuMPZjIkqXIgzG60lIGDWO00DcjSzbtyJzUTRj973fnryRs5FlnWUh3upPu9PsBHHIvIjz4-NBZKcIYnURonOVhro3HCCHLVEFXA-cTfXYZf79SVzsw6d7CUFlltyfWG7WfObojH6GfI_S0JBFf57chsUZRdrWj0LAttYL_UkOMPYBdQchYA9j9djL58XN1BOM1ZyuPY8r4a94BliZy9KuqRlW1qOuh11xUu1FvvH5bC0L_raXcW5Zze__HTqdrjur0KTxpI0x21KjEM9jJy3142HBO3u_Do_M2m_4c_PFFSIzEzf7HHBF1NKVx7KZk8waHgl2jw1rM6IKfKlaZI_KhcvbbfmYW5VYF6QzDX9YUljNPr9ybaPQFXJ6eXByfhS3rQuhUIheh9sZmRcGNj1QWUx6TK8OlsN4pX6A7T6y2SnophUHjNVlmeeacK5SxnMjYX8KgnJX5a2A5fp47L7IiV3jsHJsk1rka28JHojCZCOBTN9GpayHJiRljmjapcZnioqTNogTwoZdtJ-C_Uh9pvVKyTuzJ2faRAY6HcK7SIyU1gdKNowCGG5JoVW6j-QBXfOufhp0ypK3Z36UrJQ3gfd9MXVMpW5nPlnd41pIYY8Uy5ltkCEIpwujYbJMxmsIzOQ7gVaOD_XAJUUdrkQQw3tDOXoBAxTdbypvrGlwcHY6WHMd_2Ovxlll4s30W3sJjUdOHUE3eEAaLapm_wyBukR20lvkXOmlJkA priority: 102 providerName: ProQuest – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdGJz5e-BgDCmUyYhLiIc2HY8fhrZo2TUibeFil8RT5I9EGJa3SVGj89dzVTlkAVUi8VfLFdc7n88_x3e8IOYxsEsPBxwZGsSRIYZMIpFFRUAppASFozSv8NHB2Lk6n6cdLfrlDjrtcGOWjwsddSsOXpgm9EoOFrUKehjzMmQwBGbMU7DVsmhYsdQyNd8iu4ADJB2R3ev5p8hm9cJri3b7PFobfecyzjqY0Z-vuXQe9jcm7517O2y3o-WcE5f1VvVA339Vsdmt7OnnkwkiWa1ZDjEr5Ol61emx-_Mb5-N9v_pg89ACWTtwjT8hOWe-Ru66k5c0euXfmL-ufEnt0EWDBY-deqcE6IC7yjl7XdOFoLugV7IftHO8PMCCWGqxtVM-_qQ9UgdyveHcK6Jq6uHVqMYnegd19Mj05vjg6DXxRh8DwnLWBsFLpqoqkjblO8Zo04jJiibKG2wrQQq6E4swylkjwDVJrFWljTMWlirDW-zMyqOd1-YLQEh4vjU10VXI41WYyT0XJM1XZOKmkTobkfTejhfGM51h4Y1a4m3dWgIoLp8QhebuR9Qr4q9Q7NIwCFz_0ZLo5g_EgjVYx4Uwg510WD8moJwmL1vSaD2Cat_7TqLO6wnuVZQFYDxkE8xxe7c2mGbvGSLm6nK-WcJRjAOFSlkZbZJChKQbwLbfJSIHoj2VD8twZ-2a4SNgjRJIPSdZbBhsB5Czvt9TXV2vuctjPBItg_IebBbNFCy__TewVeZCsq5Rg6N-IDNpmVb4GrNjqA-8JfgKR02mR priority: 102 providerName: Unpaywall |
| Title | CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23616629 https://www.proquest.com/docview/3170876992 https://www.proquest.com/docview/1431294340 https://www.proquest.com/docview/1732810838 https://www.proquest.com/docview/1786181237 https://pubmed.ncbi.nlm.nih.gov/PMC3766302 https://academic.oup.com/jrr/article-pdf/54/5/938/11834703/rrt030.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 54 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: DOA dateStart: 19990101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Inspec with Full Text customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: ADMLS dateStart: 20110901 isFulltext: true titleUrlDefault: https://www.ebsco.com/products/research-databases/inspec-full-text providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: DIK dateStart: 19600101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: GX1 dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection (WRLC) customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: TOX dateStart: 19600601 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: 7X7 dateStart: 19960101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1349-9157 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: BENPR dateStart: 19960101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Open Access Journals customDbUrl: eissn: 1349-9157 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0027050 issn: 1349-9157 databaseCode: M48 dateStart: 20120101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED_tQ3y8IBgfK5TKiEmIh2xuHDsOEkJlWpmQWibUSuUpcuxEG-rSkbWC_vfcJWm3iKniJS--JI7vnLuzz78fwAF3fhcTH-dZI3wvQCfhaWu4lyrtMEJIEpnR0sBgqE7HwdeJnGzBir-zHsDrO1M74pMaF9PDP7-Wn3DCf6zBkI5-FsVRUczRXLdhFz1URBQOg0DfJF68ZGrlQUD7_IqvYEob9zYcU_17bpx5uxV6_ltB-WCRX5nlbzOd3nJP_cfwqI4rWa8yhCewleZ7cK9imlzuwf1BvYf-FNzxyCMe4uqvxyzRc1QFcewiZ1cV-gQ7Rzc1n9GyPtWpMkuUQ_ns0nxgBuVuytAZBr2sKidnjs62VzHoMxj3T0bHp17NteBZGYm5p5w2SZZx7boyCWj3kkvNhW-clS5DJx4ZZaRwQvgap6xOEsMTa20mteFEwf4cdvJZnu4DS_H21Do_yVKJyWaoo0ClMjSZ6_qZTvwWvF8NdGxrIHLiw5jG1Ya4iFEpcaWUFrxdy9YDcKfUO9JXTFaCT7KmPlqA_SF0q7gnhSIourDbgnZDEueSbTR3UOMb39ReGUO8stUYQzAC9osi_LQ362Z6NBWw5elscY0ZlsDIKhAB3yBDwEldjIn1JhmtKCgTYQteVDa47i7h6CjlRy0IG9a5FiAo8WZLfnFeQoqjm1GCY_8P1na8YRRe_pdWXsFDv-QOoYK8NuzMi0X6GiO4edKB7XAS4lX3v3Rg9_PJ8Ox7p1wN6ZQTF6-jbxNsGQ_Pej_-AiUNT9c |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIRgvCAaMjDKMGEI8RHXt2HGQEJoGU8fWPXVS34JjJ9pQSbt-aOo_xd_IXZx0rUB927MvieX7zp1_R8ghc7wDiY8LrRE8jMBJhNoaFuZKO4gQskwW-Gugd6G6l9GPgRxskT_NXRhsq2xsYmWo3cjiP_I2-DlET0sS_nV8E-LUKKyuNiM0vFic5YtbSNmmX06_AX8_cH7yvX_cDeupAqGViZiFymmTFQXTriOzCOt0TGomuHFWugLcVWKUkcIJwTUIp84ywzJrbSG1YbwCOgCT_yASYEtAf-LBSoLHqomwLIqwn0CxBg41Ee1fk0l7MplV3dYrDrB2A2t361ZC3H87NXfm5dgsbs1wuOIGT56SJ3X8So-8wD0jW3m5Sx76iZaLXfKoV9fqnxN33A9x3rG3rtTiGBDfeEevSzr2KBf0CtzhbITlA-yHpRZHG5Wj3-YzNUB31-5OIbimvm2dOrxD72PdF-TyXk7_JdkuR2X-itAcHs-t41mRS0hqY51EKpexKVyHFzrjAfnUHHRqa8BznLsxTH3hXaTAlNQzJSDvl7T1AfyX6iPyK0XdhzdZU19hgP0gilZ6JIVCyLu4E5DWGiXorF1bPgCOb_xSqxGGtDYq0_ROBQLybrmMr8ZGuTIfzaeQyQmI4CIRsQ00CNDUgdhbb6LRCoM_EQdkz8vgcruI16MUTwISr0nnkgAhy9dXyuurCroc3JkSDPZ_uJTjDaewv_kU3pKdbr93np6fXpy9Jo95NagEu_9aZHs2medvIFycZQeVjlLy876Nwl-_0n-J |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdGJz5e-BgDCmUyYhLiIc2HY8fhrZo2TUibeFil8RT5I9EGJa3SVGj89dzVTlkAVUi8VfLFdc7n88_x3e8IOYxsEsPBxwZGsSRIYZMIpFFRUAppASFozSv8NHB2Lk6n6cdLfrlDjrtcGOWjwsddSsOXpgm9EoOFrUKehjzMmQwBGbMU7DVsmhYsdQyNd8iu4ADJB2R3ev5p8hm9cJri3b7PFobfecyzjqY0Z-vuXQe9jcm7517O2y3o-WcE5f1VvVA339Vsdmt7OnnkwkiWa1ZDjEr5Ol61emx-_Mb5-N9v_pg89ACWTtwjT8hOWe-Ru66k5c0euXfmL-ufEnt0EWDBY-deqcE6IC7yjl7XdOFoLugV7IftHO8PMCCWGqxtVM-_qQ9UgdyveHcK6Jq6uHVqMYnegd19Mj05vjg6DXxRh8DwnLWBsFLpqoqkjblO8Zo04jJiibKG2wrQQq6E4swylkjwDVJrFWljTMWlirDW-zMyqOd1-YLQEh4vjU10VXI41WYyT0XJM1XZOKmkTobkfTejhfGM51h4Y1a4m3dWgIoLp8QhebuR9Qr4q9Q7NIwCFz_0ZLo5g_EgjVYx4Uwg510WD8moJwmL1vSaD2Cat_7TqLO6wnuVZQFYDxkE8xxe7c2mGbvGSLm6nK-WcJRjAOFSlkZbZJChKQbwLbfJSIHoj2VD8twZ-2a4SNgjRJIPSdZbBhsB5Czvt9TXV2vuctjPBItg_IebBbNFCy__TewVeZCsq5Rg6N-IDNpmVb4GrNjqA-8JfgKR02mR |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CT-pathologic+correlation+in+primary+hepatocellular+carcinoma%3A+an+implication+for+target+delineation&rft.jtitle=Journal+of+radiation+research&rft.au=Chen%2C+Hai-yan&rft.au=Ma%2C+Xiu-mei&rft.au=Ye%2C+Ming&rft.au=Hou%2C+Yan-li&rft.date=2013-09-01&rft.issn=0449-3060&rft.eissn=1349-9157&rft.volume=54&rft.issue=5&rft.spage=938&rft.epage=942&rft_id=info:doi/10.1093%2Fjrr%2Frrt030&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_jrr_rrt030 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0449-3060&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0449-3060&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0449-3060&client=summon |